Sign in
Long Term Results of Pro Re Nata Regimen of Aflibercept Treatment in Recurrent or Persistent Neovascular Age-Releated Macular Degeneration
ILKAY KILIC MUFTUOGLU, MD
Annual Meeting Talks
2016
HIPPA and Malpractice Pitfalls in Providing Care to Infants at Risk for Retinopathy of Prematurity (ROP) For Physicians Employing Digital Imaging Technologies
Antonio Capone, MD
Interim Results and Key Learnings from an Ongoing Phase 2 Study of Encapsulated Cell Therapy Compared to Aflibercept in Patients With Wet AMD
Szilárd Kiss, MD
Category: Ocular Oncology